199 related articles for article (PubMed ID: 9845376)
41. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
[TBL] [Abstract][Full Text] [Related]
42. Aberrant markers expression in T- and B-lymphoid and myeloid leukemia cells of different differentiation stages.
Babusíková O; Koníková E; Kusenda J; Koubek K
Neoplasma; 1999; 46(5):277-82. PubMed ID: 10665842
[TBL] [Abstract][Full Text] [Related]
43. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
44. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
45. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
[TBL] [Abstract][Full Text] [Related]
46. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?
Mason KD; Juneja SK; Szer J
Blood Rev; 2006 Mar; 20(2):71-82. PubMed ID: 16185796
[TBL] [Abstract][Full Text] [Related]
47. Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan.
Chen SW; Li CF; Chuang SS; Tzeng CC; Hsieh YC; Lee PS; Chen CH; Huang WT; Hwang WS; Tsao CJ
Int J Lab Hematol; 2008 Apr; 30(2):133-8. PubMed ID: 18333845
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of clinical usefulness of immunophenotyping of leukemia using the immunofluorescence and immunoenzyme APAAP methods].
Stella-Hołowiecka B; Jagoda K; Koehler M; Krzemień S; Hołowiecki J
Acta Haematol Pol; 1992; 23(2):87-94. PubMed ID: 1488865
[TBL] [Abstract][Full Text] [Related]
49. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
Al-Mawali A; Gillis D; Hissaria P; Lewis I
Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
51. Application of series of monoclonal antibodies against human white cell differentiation antigens and the common ALL antigen in the characterization of leukemia cells.
Hołowiecki J; Stella-Hołowiecka B; Krawczyk-Kuliś M; Wiechnik E; Japa J; Jarczok K; Rudzka E; Duraj M
Arch Immunol Ther Exp (Warsz); 1984; 32(1):43-9. PubMed ID: 6433853
[TBL] [Abstract][Full Text] [Related]
52. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
[TBL] [Abstract][Full Text] [Related]
53. Exposure by desialylation of myeloid antigens on acute lymphoblastic leukemia cells.
Stockinger H; Majdic O; Liszka K; Aberer W; Bettelheim P; Lutz D; Knapp W
J Natl Cancer Inst; 1984 Jul; 73(1):7-11. PubMed ID: 6204096
[TBL] [Abstract][Full Text] [Related]
54. Initial characterization of an anti-CD5 monoclonal antibody obtained from leukemic cells infiltrating lymphocytes.
Delfini C; Centis F; Muretto P; Staccioli MP; Pazzaglia C
Haematologica; 1993; 78(3):145-50. PubMed ID: 7690732
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
Babusíková O; Hrivnáková A; Cáp J; Ujházy P
Neoplasma; 1988; 35(6):683-90. PubMed ID: 2975765
[TBL] [Abstract][Full Text] [Related]
56. [IKO-GM-1 monoclonal antibodies in the diagnosis of acute nonlymphoblastic leukemias].
Kryzhanov MA; Tupitsin NN; Savel'eva EV; Shishkin IuV; Drozdova TS
Vopr Onkol; 1985; 31(7):79-83. PubMed ID: 3861027
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
[TBL] [Abstract][Full Text] [Related]
58. Refractory T cell acute lymphoblastic leukemia with unusual karyotype and interesting immunophenotype.
Anreder MB; Mitruka BM; Gill J; Varela M; Rozans MK; Krause JR
J La State Med Soc; 1996 Dec; 148(12):521-4. PubMed ID: 8990795
[TBL] [Abstract][Full Text] [Related]
59. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression.
Salamone MC; Roisman FR; Santiago J; Satz ML; Fainboim L
Dis Markers; 1990; 8(5):265-74. PubMed ID: 1707769
[TBL] [Abstract][Full Text] [Related]
60. Acute non-lymphocytic leukemia with expression of surface antigen CD7--morphological, cytochemical, immunological and ultrastructural features in eight patients.
Chopra HK; Nair CN; Barbhaya SA; Dhond SR; Badrinath Y; Kumar A; Zachariah LV; Advani SH
Indian J Cancer; 1993 Jun; 30(2):48-54. PubMed ID: 7693579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]